Cover Image

Plasma Nitrate Levels Are Related to Metabolic Syndrome and Are Not Altered by Treatment with DPP-4 Inhibitor Linagliptin: A Randomised, Placebo-Controlled Trial in Patients with Early Type 2 Diabetes Mellitus

The depletion of nitrate and nitrite, stable nitric oxide (NO) end-products, promotes adipose tissue dysfunction and insulin resistance (IR). Dipeptidyl peptidase-4 (DPP-4) inhibitors have the potentially beneficial side effect of increasing NO availability. In this study, nitrate and nitrite levels...

Full description

Saved in:

Bibliographic Details
Main Authors:	Melanie Reijrink (Author), Stefanie A. De Boer (Author), Anniek M. Van Roon (Author), Riemer H. J. A. Slart (Author), Bernadette O. Fernandez (Author), Martin Feelisch (Author), Hiddo J. L. Heerspink (Author), Harry Van Goor (Author), Jan-Luuk Hillebrands (Author), Douwe J. Mulder (Author)
Format:	Book
Published:	MDPI AG, 2021-09-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

A dipeptidyl peptidase-4 (DPP-4) inhibitor, linagliptin, attenuates cardiac dysfunction after myocardial infarction independently of DPP-4
by: Takehiro Yamaguchi, et al.
Published: (2019)

DPP-4 Inhibitor Linagliptin Ameliorates Oxidized LDL-Induced THP-1 Macrophage Foam Cell Formation and Inflammation
by: Wang H, et al.
Published: (2020)

Population Pharmacokinetic/Pharmacodynamic Analysis of the DPP-4 Inhibitor Linagliptin in Japanese Patients with Type 2 Diabetes Mellitus
by: Yusuke Tadayasu, et al.
Published: (2013)

Elucidation of DPP‐4 involvement in systemic distribution and renal reabsorption of linagliptin by PBPK modeling with a cluster Gauss-Newton method
by: Ryo Nakamura, et al.
Published: (2024)

Linagliptin: from bench to bedside
by: Doupis J
Published: (2014)

Release of High-Mobility Group Box-1 after a Raynaud's Attack Leads to Fibroblast Activation and Interferon-γ Induced Protein-10 Production: Role in Systemic Sclerosis Pathogenesis
by: Yehya Al-Adwi, et al.
Published: (2023)

Cardiac Protection by Oral Sodium Thiosulfate in a Rat Model of L-NNA-Induced Heart Disease
by: Isabel T. N. Nguyen, et al.
Published: (2021)

Capillary microscopy is a potential screening method for connective tissue disease in children with Raynaud's phenomenon
by: Claudette A. Farenhorst, et al.
Published: (2022)

Editorial: Sodium Glucose Co-Transporter 2 Inhibitors and Kidney Function
by: Daniel H. Van Raalte, et al.
Published: (2022)

Progress and opportunities in measuring the burden of Chronic Kidney Disease
by: Priya Vart, et al.
Published: (2022)

The clinical application of linagliptin in Asians
by: Cao CQ, et al.
Published: (2015)

Analytical Enantio-Separation of Linagliptin in Linagliptin and Metformin HCl Dosage Forms by Applying Two-Level Factorial Design
by: Sushant B. Jadhav, et al.
Published: (2016)

Kinetics of endothelin-1 and effect selective ETA antagonism on ETB activation: a mathematical modeling analysis
by: K. Melissa Hallow, et al.
Published: (2024)

Precision-cut kidney slices (PCKS) to study development of renal fibrosis and efficacy of drug targeting ex vivo
by: Fariba Poosti, et al.
Published: (2015)

Establishment of a selective evaluation method for DPP4 inhibitors based on recombinant human DPP8 and DPP9 proteins
by: Jinglong Liu, et al.
Published: (2014)

Repositioning of Hypoglycemic Drug Linagliptin for Cancer Treatment
by: Yong Li, et al.
Published: (2020)

Anti-Inflammatory Action of Sitagliptin and Linagliptin in Doxorubicin Nephropathy
by: Chor Ho Jo, et al.
Published: (2018)

Linagliptin-Associated Bullous Pemphigoid: The First Case in China
by: Yang-Chun Liu, et al.
Published: (2020)

Post-marketing Study of Linagliptin: A Pilot Study
by: Gabrielle Kéfrem Alves Gomes, et al.
Published: (2019)

Cooking behaviours after Diabetes Prevention Program (DPP) participation among DPP participants in Baltimore, MD
by: Lauren E Russell, et al.
Published: (2023)

Linagliptin Inhibits Lipopolysaccharide-Induced Inflammation Concentration-Dependently And -Independently
by: Sato N, et al.
Published: (2019)

The Roles of Dipeptidyl Peptidase 4 (DPP4) and DPP4 Inhibitors in Different Lung Diseases: New Evidence
by: Tianli Zhang, et al.
Published: (2021)

Renoprotective Effects of DPP-4 Inhibitors
by: Daiji Kawanami, et al.
Published: (2021)

A Pharmacokinetic Drug Interaction Between Fimasartan and Linagliptin in Healthy Volunteers
by: Kang WY, et al.
Published: (2020)

Linagliptin inhibits lipopolysaccharide-induced inflammation in human U937 monocytes
by: Shiho Yamadera, et al.
Published: (2018)

Cardiac PET Imaging of ATP Binding Cassette (ABC) Transporters: Opportunities and Challenges
by: Wanling Liu, et al.
Published: (2023)

Does the evidence about health risks associated with nitrate ingestion warrant an increase of the nitrate standard for drinking water?
by: Benjamin Nigel, et al.
Published: (2006)

Linagliptin Regulates the Mitochondrial Respiratory Reserve to Alter Platelet Activation and Arterial Thrombosis
by: Yi Li, et al.
Published: (2020)

Quantifying the integrated physiological effects of endothelin-1 on cardiovascular and renal function in healthy subjects: a mathematical modeling analysis
by: Hongtao Yu, et al.
Published: (2024)

Effect of Linagliptin and Voglibose on metabolic profile in patients with Type 2 Diabetes: a randomized, double-blind, placebo-controlled trial
by: Girish Parthan, et al.
Published: (2018)

Effects of AEDs on Serum Nitrite and Nitrate Levels
by: J Gordon Millichap
Published: (2004)

DPP4 as a Potential Candidate in Cardiovascular Disease
by: Chen SY, et al.
Published: (2022)

Evaluation of the University of California Diabetes Prevention Program (UC DPP) Initiative
by: Maryam Gholami, et al.
Published: (2021)

A case of irritant contact dermatitis and suspected linagliptin-induced koebnerized bullous pemphigoid
by: Austin Ambur, DO, et al.
Published: (2020)

Management of patients with type 2 diabetes and mild/moderate renal impairment: profile of linagliptin
by: Gallwitz B
Published: (2015)

Development of depot PLGA-based in-situ implant of Linagliptin: Sustained release and glycemic control
by: Eman Gomaa, et al.
Published: (2023)

Non Incretin Effects of DPP-4 Inhibitors: Comparative Study
by: A Shabbir Ali Bhatti, et al.
Published: (2019)

Systemic Oxidative Stress in Severe Early-Onset Fetal Growth Restriction Associates with Concomitant Pre-Eclampsia, Not with Severity of Fetal Growth Restriction
by: Marjon E. Feenstra, et al.
Published: (2023)

Type 2 Diabetes and its Treatment with Linagliptin are both Associated with Elevated Mortality in Bullous Pemphigoid
by: Päivi Leisti, et al.
Published: (2024)

Initial combination therapy for patients with type 2 diabetes mellitus: considerations for metformin plus linagliptin
by: Jeffrey Freeman
Published: (2013)